Kolexia
Duvivier Claudine
Médecine générale
Hôpital Necker Enfants Malades
Paris, France
161 Activités
2 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Hépatite Hépatite C Co-infection Syndrome d'immunodéficience acquise Hépatite C chronique Diabète Maladies transmissibles Maladies virales

Industries

MSD
27 collaboration(s)
Dernière en 2023
ViiV Healthcare
13 collaboration(s)
Dernière en 2023
Gilead
8 collaboration(s)
Dernière en 2023
OVERCOME
1 collaboration(s)
Dernière en 2020

Dernières activités

Dataids_PEC: Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients
Essai Clinique (DatAids)   26 février 2024
Dat'Aids Prevention: HIV Prevention in France : "Dat'AIDS Prevention"
Essai Clinique (DatAids)   26 février 2024
Differences in integrated assessment and management of non-communicable diseases (NCDs) for people with HIV across the WHO European region.
HIV medicine   15 février 2024
Can we drug reduce antiretroviral regimen with dual NRTI regimen in naïve patients with viral load <50,000 copies/mL and CD4>300 cells/μL?: Results from a randomized non-inferiority ANRS 173 ALTAR trial
HIV medicine Congress 2023   01 décembre 2023
Sexual health in a student population: Knowledge and impact of COVID
HIV medicine Congress 2023   01 décembre 2023
Doravirine plus dolutegravir two-drug regimen as a maintenance ART: Results from a French cohort study
HIV medicine Congress 2023   01 décembre 2023
Self-questionnaire on sexual-health collected from young people during a festival
HIV medicine Congress 2023   01 décembre 2023
High proportion of post-migration HIV acquisition in immigrant men who have sex with men receiving HIV care in France, and association with social disadvantage and sexual behaviours: Results of the ANRS-MIE GANYMEDE study
HIV medicine Congress 2023   01 décembre 2023
Penetration of doravirine combined to raltegravir in semen: Preliminary results of the DORAL switch study
HIV medicine Congress 2023   01 décembre 2023
RHIVIERA-02: A Randomised Phase II Placebo-controlled Trial of Antiretroviral Therapy (ART) Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs) vs ART Plus Placebo During Primary HIV-1 Infection to Study the Impact on Post-treatment HIV Control.
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   10 novembre 2023